| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 734052 | 86532 | STREFEN 8,75 MG PASTILLAS PARA CHUPAR SABOR MIEL Y EUCALIPTO | STREFEN 8,75 MG PASTILLAS PARA CHUPAR SABOR MIEL Y EUCALIPTO, 16 pastillas | 8,75 | 5 | 16 | 29 | 16 pastillas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86532/86532_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86532/86532_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7742 | RECKITT BENCKISER HEALTHCARE S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-04 | 2022-04-04 | 1 | 2024-07-09 | View Edit Delete | ||||||||||||
| 734049 | 86798 | SUGAMMADEX AVALON 100 MG/ML SOLUCION INYECTABLE EFG | SUGAMMADEX AVALON 100 MG/ML SOLUCION INYECTABLE EFG, 10 viales de 2 ml | 100 mg/ml inyectable 2 ml | 45 | 10 | 34 | 10 viales de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86798/86798_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86798/86798_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34734 | AVALON LABORATORIOS S.L. | 2022-04-04 | 1 | 1 | 1 | 2025-05-29 | 2025-05-29 | 1 | 2025-08-13 | View Edit Delete | ||||||||||||
| 734048 | 86797 | FENOFIBRATO PENSA PHARMA 145 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | FENOFIBRATO PENSA PHARMA 145 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 145 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86797/86797_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86797/86797_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 734047 | 86796 | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86796/86796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86796/86796_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734046 | 86796 | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86796/86796_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86796/86796_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734045 | 86795 | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86795/86795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86795/86795_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734044 | 86795 | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86795/86795_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86795/86795_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734043 | 86794 | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86794/86794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86794/86794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734042 | 86794 | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 40 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86794/86794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86794/86794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734041 | 86793 | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimdos | 80 mg | 6 | 28 | 10 | 28 comprimdos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86793/86793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86793/86793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734040 | 86793 | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA NORMOGEN 80 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86793/86793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86793/86793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-06-10 | View Edit Delete | ||||||||||||
| 734039 | 86792 | VILDAGLIPTINA/METFORMINA NORMON 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VILDAGLIPTINA/METFORMINA NORMON 50 MG/850 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 50 mg/850 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86792/86792_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86792/86792_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 0 | 2022-10-11 | View Edit Delete | ||||||||||||
| 734037 | 86791 | VILDAGLIPTINA/METFORMINA NORMON 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VILDAGLIPTINA/METFORMINA NORMON 50 MG/1.000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 50 mg/1.000 mh | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86791/86791_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86791/86791_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 0 | 2022-10-11 | View Edit Delete | ||||||||||||
| 734036 | 86790 | PEMETREXED GLENMARK 10 MG/ML SOLUCION PARA PERFUSION | PEMETREXED GLENMARK 10 MG/ML SOLUCION PARA PERFUSION, 1 vial de 100 ml | 10 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86790/86790_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86790/86790_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28557 | GLENMARK FARMACEUTICA S.L.U | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2023-10-19 | View Edit Delete | ||||||||||||
| 734033 | 86789 | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86789/86789_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86789/86789_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2023-03-28 | View Edit Delete | ||||||||||||
| 734032 | 86788 | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 40 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86788/86788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86788/86788_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2023-04-01 | View Edit Delete | ||||||||||||
| 734031 | 86787 | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 20 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 20 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86787/86787_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86787/86787_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2023-04-01 | View Edit Delete | ||||||||||||
| 734030 | 86786 | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | OLMESARTAN/HIDROCLOROTIAZIDA TEVA 20 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86786/86786_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86786/86786_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-11-14 | View Edit Delete | ||||||||||||
| 734028 | 86785 | DESVENLAFAXINA NEURAXPHARM 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | DESVENLAFAXINA NEURAXPHARM 50 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/PVC/PE/PVDC) | 50 mg | 5 | 28 | 10 | 28 comprimidos (Al/PVC/PE/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86785/86785_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86785/86785_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 0 | 2022-09-15 | View Edit Delete | ||||||||||||
| 734026 | 86784 | DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG | DESVENLAFAXINA NEURAXPHARM 100 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG, 28 comprimidos (Al/PVC/PE/PVDC) | 100 mg | 5 | 28 | 10 | 28 comprimidos (Al/PVC/PE/PVDC) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86784/86784_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86784/86784_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2022-04-04 | 1 | 1 | 1 | 2022-04-05 | 2022-04-04 | 1 | 2022-09-15 | View Edit Delete |
Page 251 of 1036, showing 20 records out of 20703 total, starting on record 5001, ending on 5020